Service contract to cover the genetics branch perkinelmer ensight system period of performance 01/01/20-12/31/20

Ended Purchase Order Awarded Last action

Contract number
75N91020P00118
Awardee
Awarding agency
Obligated
$18,108

Award facts

Contract value 100% obligated
$18,108.48 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
811219 Other Electronic and Precision Equipment Repair and Maintenance
PSC
J066 Maint/Repair/Rebuild Of Equipment- Instruments And Laboratory Equipment
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute issued a purchase order to Revvity Health Sciences, Inc. for $18,108.48 on December 31, 2019, to provide service coverage for the Genetics Branch PerkinElmer Ensight system during the period January 1, 2020 through December 31, 2020. No set-aside was used. Work is performed at Bethesda, Maryland. The order is firm fixed-price with no further period of performance extensions noted.

Quick answers

Who was awarded contract 75N91020P00118?

75N91020P00118 was awarded to Revvity Health Sciences, Inc. by National Cancer Institute (National Institutes of Health) on December 31, 2019.

How much is contract 75N91020P00118 worth?

The government has obligated $18,108 on 75N91020P00118.

Was contract 75N91020P00118 competed?

The extent of competition for 75N91020P00118 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award